This website uses cookies to ensure you get the best experience.

Magle Group and our selected partners use cookies and similar technologies (together “cookies”) that are necessary to present this website, and to ensure you get the best experience of it. If you consent to it, we will also use cookies for analytics purposes.

See our Cookie Policy to read more about the cookies we set.

You can withdraw and manage your consent at any time, by clicking “Manage cookies” at the bottom of each website page.

Select which cookies you accept

On this site, we always set cookies that are strictly necessary, meaning they are necessary for the site to function properly.

If you consent to it, we will also set other types of cookies. You can provide or withdraw your consent to the different types of cookies using the toggles below. You can change or withdraw your consent at any time, by clicking the link “Manage Cookies”, that is always available at the bottom of the site.

To learn more about what the different types of cookies do, how your data is used when they are set etc, see our Cookie Policy.

These cookies are necessary to make the site work properly, and are always set when you visit the site.

Vendors Teamtailor

These cookies collect information to help us understand how the site is being used.

Vendors Teamtailor
Magle Group career site
Our organization

Magle Biopharma

Connect

We are a stem cell focused CDMO.

Magle Biopharma, a proud member of the renowned Magle Group, is based in Sweden and is a leading Contract Development and Manufacturing Organization (CDMO). We specialize in the development and production of stem cell-based therapies for both investigational and GMP use.

With expertise, cutting-edge facilities, and a commitment to excellence, we provide comprehensive support to ensure the success of your therapeutic innovations from inception to market. At Magle Biopharma, we leverage our deep industry knowledge, innovative technologies, and robust processes to deliver unparalleled results.

240117 - 1138 - GAB00564.jpg

About Magle Group

Magle AB (formed in 1995 as a pure development company) acquired Chemoswed AB (formed in 1944 as a manufacturing company) in 2016 before merging the companies in 2017 to form Magle Chemoswed. In 2019, Adroit Science AB was acquired to increase the development services segment. In 2021, PharmaCept GmbH was acquired as a first step to develop a sales and marketing organization for DSM products. Most recent to join the Magle Group is Magle Biopolymers - a CDMO part of the group focusing on Dextran technology.

Founded in Magle Group 2016
Coworkers Growing 150+ Team members

Already working at Magle Group?

Let’s recruit together and find your next colleague.

@maglechemoswed.com